Biberach, Germany

Heike-Andrea Wieland



Average Co-Inventor Count = 7.2

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Biberach, DE (1999 - 2000)
  • Bad Soden, DE (2008)

Company Filing History:


Years Active: 1999-2008

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Heike-Andrea Wieland: Innovator in Pharmaceutical Chemistry

Introduction

Heike-Andrea Wieland is a prominent inventor based in Biberach, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target metabolic and eating disorders. With a total of 4 patents to her name, her work has the potential to impact the treatment of various health conditions.

Latest Patents

Wieland's latest patents include innovative amide compounds that exhibit MCH-antagonistic activity. These compounds are described by a general formula, where specific groups and residues are defined in detail. The invention also encompasses pharmaceutical compositions that incorporate these amide compounds. Given their MCH receptor-antagonistic activity, these compositions are particularly suitable for treating metabolic disorders and eating disorders, including obesity, bulimia, anorexia, hyperphagia, and diabetes. Another notable patent involves amino acid derivatives that serve as NPY-antagonistic compounds, showcasing her diverse expertise in pharmaceutical formulations.

Career Highlights

Throughout her career, Heike-Andrea Wieland has worked with reputable companies in the pharmaceutical industry. Notably, she has been associated with Dr. Karl Thomae GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in drug development.

Collaborations

Wieland has collaborated with esteemed colleagues, including Klaus Rudolf and Wolfhard Engel. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.

Conclusion

Heike-Andrea Wieland stands out as a significant figure in pharmaceutical innovation. Her contributions to the development of therapeutic compounds highlight her dedication to improving health outcomes. With her ongoing research and patent portfolio, she continues to pave the way for advancements in the treatment of metabolic and eating disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…